| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
61,297 |
46,164 |
$4.95M |
| 99051 |
|
17,587 |
13,532 |
$180K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
41,102 |
32,787 |
$826.20 |
| 0002A |
|
137 |
91 |
$36.78 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
9,456 |
6,222 |
$35.00 |
| 91300 |
|
371 |
229 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,044 |
4,941 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,442 |
1,858 |
$0.00 |
| 81025 |
|
3,319 |
2,616 |
$0.00 |
| 81003 |
|
8,088 |
5,594 |
$0.00 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
32 |
25 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
817 |
652 |
$0.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
21 |
12 |
$0.00 |
| 0071A |
|
37 |
33 |
$0.00 |
| 91313 |
|
13 |
12 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
48 |
41 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
15 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
57 |
52 |
$0.00 |
| 0013A |
|
146 |
89 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,673 |
1,180 |
$0.00 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
3,101 |
2,410 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,205 |
5,523 |
$0.00 |
| 99000 |
|
12,154 |
9,023 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,474 |
3,683 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,622 |
1,403 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,005 |
3,140 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
495 |
332 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
295 |
194 |
$0.00 |
| 0001A |
|
135 |
89 |
$0.00 |
| 0051A |
|
65 |
54 |
$0.00 |
| 91301 |
|
497 |
344 |
$0.00 |
| 36416 |
|
105 |
92 |
$0.00 |
| 82962 |
|
79 |
63 |
$0.00 |
| 87807 |
|
122 |
102 |
$0.00 |
| 91305 |
|
200 |
161 |
$0.00 |
| 0072A |
|
54 |
46 |
$0.00 |
| 91307 |
|
106 |
82 |
$0.00 |
| 0134A |
|
13 |
12 |
$0.00 |
| 0011A |
|
96 |
59 |
$0.00 |
| 0012A |
|
88 |
47 |
$0.00 |
| 0052A |
|
48 |
33 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
23 |
12 |
$0.00 |
| 90686 |
|
36 |
14 |
$0.00 |